Moxetumomab pasudotox - AbsoluteAstronomy.com

Moxetumomab pasudotox is a mouse monoclonal antibody designed for the treatment of cancer.

Moxetumomab pasudotox was developed by MedImmune

MedImmune

MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise...

, Inc.

The source of this article is wikipedia, the free encyclopedia. The text of this article is licensed under the GFDL.